FRANKFURT, March 20 (Reuters) - Swiss drugmaker Novartis on Friday agreed to buy a breast cancer drug candidate for up to $3 billion from U.S. biotech firm Synnovation Therapeutics, adding a targeted therapy to its pipeline of cancer drugs. The company will pay $2 billion upfront and up to $1 billion that is contingent on further development achievements as part...

04:40 AM EDT, 03/20/2026 (MT Newswires) -- Benjamin A. Hardesty, Director, on March 19, 2026, sold 12,000 shares in Antero Resources ( AR ) for $528,000. Following the Form 4 filing with the SEC, Hardesty has control over a total of 150,742 common shares of the company, with 150,242 shares held directly and 500 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1433270/000110465926032266/xslF345X05/tm269417-1_4seq1.xml ...

04:40 AM EDT, 03/20/2026 (MT Newswires) -- Samuel Yount, Chief Business Officer, on March 17, 2026, sold 71,988 shares in Nerdwallet ( NRDS ) for $742,774. Following the Form 4 filing with the SEC, Yount has control over a total of 607,551 Class A common shares of the company, with 433,578 shares held directly and 173,973 controlled indirectly. SEC Filing:...

04:40 AM EDT, 03/20/2026 (MT Newswires) -- (Updates with additional details in the fifth and sixth paragraphs and the stock movement in the seventh paragraph.) Gemini Space Station ( GEMI ) reported a Q4 loss late Thursday of $1.22 per diluted share, narrowing from a loss of $5.49 a year earlier. Analysts surveyed by FactSet expected a loss of $1.04....